Healthcare Analyst Stanton, along with a key opinion leader discuss the impact of an ADHERE trial result on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) treatment on an Analyst/Industry conference call to be held on August 9 at 6 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CSLLY: